Streptococcal mutanobactin mediates interspecies competition with gram-positive bacteria.

Streptococcus mutans produces mutanobactin, which kills gram-positive bacteria, including antibiotic-resistant strains, and prevents E. faecalis biofilm formation.

• Why it matters: Understanding natural bacterial competition can reveal new antimicrobial compounds to combat drug-resistant infections, addressing a critical gap in current therapeutics.
• What they did: Researchers co-cultured oral bacteria and identified that multiple S. mutans strains produce mutanobactin, a cyclic lipopeptide that increases membrane permeability and kills target bacteria in a contact-dependent manner.
• The result: Mutanobactin effectively kills E. faecalis and other pathogens, inhibits biofilm formation, and its activity is countered by E. faecalis gelatinase, providing insights into bacterial competition and potential antibiotic development.